Stock info Iovance Biotherapeutics Inc | Filter  Basic-Info

Stock: Iovance Biotherapeutics Inc (US broad)

Last Price 1.88 Max Price 13.88
Min Price 1.66 1 Year return 0.00
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USA

Sector Review Iovance Biotherapeutics Inc

Loading...
Year Turnover Total sector Market share
2019 0 156,726 0.00 %
2020 0 195,018 0.00 %
2021 0 263,618 0.00 %
2022 0 292,194 0.00 %
2023 1 251,672 0.00 %

Advice Iovance Biotherapeutics Inc

No Records Found



News Iovance Biotherapeutics Inc

No Records Found

Annual reports Iovance Biotherapeutics Inc

No Records Found

Profile Iovance Biotherapeutics Inc

No Records Found

Results Iovance Biotherapeutics Inc

Results
2015
2016
2017
2018
2019
2020
Revenue
0
0
0
0
0
Costs
27
102
92
123
197
259
Profit
-27
-102
-92
-123
-197
-259
Margin of profit
0.0
0.0
0.0
0.0
0.0
ROI
-25.96
-61.45
-63.45
-26.39
-66.11
-39.48

Balance Iovance Biotherapeutics Inc

Balance
2015
2016
2017
2018
2019
2020
Equity
104
166
145
466
298
656
Debt
1
5
10
14
46
112
Total assets
105
171
155
480
344
768
Solvency
99.05
97.08
93.55
97.08
86.63
85.42
Cash
103
166
145
468
307
629
Cashflow
-18
-32
-78
-101
-158
-205
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-18.00
-6.40
-7.80
-7.21
-3.43
-1.83

Details Iovance Biotherapeutics Inc

Details
2016
2017
2018
2019
2020
Price
7.72
6.95
8.00
8.85
27.68
Eps
-1.00
-1.00
-1.00
-1.00
-1.00
Price/earnings-ratio
-7.72
-6.95
-8.00
-8.85
-1.88
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
2.67
1.98
3.78
2.36
4.47
Market to book
0.35
0.29
0.47
0.27
2.38
Cashflow per stock
-0.51
-1.07
-0.82
-1.25
-1.40
Stocks
62
73
123
126
147
Market Cap
480.56
508.50
987.33
1.118.75
276.13

Dividend Iovance Biotherapeutics Inc

Price info Iovance Biotherapeutics Inc

Date
Price
25 Jun 2025
1.88
20 Jun 2025
2.04
07 Jun 2025
2.05
03 Jun 2025
1.76
28 May 2025
1.73
27 May 2025
1.78
19 May 2025
1.66
09 May 2025
3.17
01 May 2025
3.59
29 Apr 2025
3.61
22 Apr 2025
3.08
03 Apr 2025
3.54
30 Mar 2025
3.56
15 Mar 2025
3.59
12 Mar 2025
3.90
01 Mar 2025
4.24
25 Feb 2025
5.55
23 Feb 2025
5.78
18 Feb 2025
5.57
13 Feb 2025
5.34
12 Feb 2025
5.29
07 Feb 2025
5.88
05 Feb 2025
5.81
02 Feb 2025
5.85
21 Jan 2025
5.91
17 Jan 2025
5.76
09 Jan 2025
7.17
17 Dec 2024
7.84
10 Dec 2024
8.94
06 Dec 2024
8.47
Overig aandelennieuws
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics Appoints Wendy L. Dixon, Ph.D., to Board of Directors
Iovance Biotherapeutics to Present at Upcoming Conferences
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics to Present at Chardan Genetic Medicines and Cell Therapy Manufacturing Summit
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Analist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2025 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo